These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 23520034)

  • 1. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies.
    Kleyer A; Finzel S; Rech J; Manger B; Krieter M; Faustini F; Araujo E; Hueber AJ; Harre U; Engelke K; Schett G
    Ann Rheum Dis; 2014 May; 73(5):854-60. PubMed ID: 23520034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alveolar bone loss is associated with circulating anti-citrullinated protein antibody (ACPA) in patients with rheumatoid arthritis.
    Gonzalez SM; Payne JB; Yu F; Thiele GM; Erickson AR; Johnson PG; Schmid MJ; Cannon GW; Kerr GS; Reimold AM; Sokolove J; Robinson WH; Mikuls TR
    J Periodontol; 2015 Feb; 86(2):222-31. PubMed ID: 25299390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-citrullinated protein antibodies are associated with decreased bone mineral density: baseline data from a register of early arthritis patients.
    Llorente I; Merino L; Ortiz AM; Escolano E; González-Ortega S; García-Vicuña R; García-Vadillo JA; Castañeda S; González-Álvaro I
    Rheumatol Int; 2017 May; 37(5):799-806. PubMed ID: 28243799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
    Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
    Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical inflammation on MRI of hand and foot of anticitrullinated peptide antibody-negative arthralgia patients at risk for rheumatoid arthritis.
    van Steenbergen HW; van Nies JA; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
    Arthritis Res Ther; 2014 Apr; 16(2):R92. PubMed ID: 24721160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting joint destruction in rheumatoid arthritis with power Doppler, anti-citrullinated peptide antibody, and joint swelling.
    Kirino Y; Hama M; Takase-Minegishi K; Kunishita Y; Kishimoto D; Yoshimi R; Asami Y; Ihata A; Oba MS; Tsunoda S; Ohno S; Ueda A; Takeno M; Ishigatsubo Y
    Mod Rheumatol; 2015; 25(6):842-8. PubMed ID: 25736364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-detected osteitis is not associated with the presence or level of ACPA alone, but with the combined presence of ACPA and RF.
    Boeters DM; Nieuwenhuis WP; Verheul MK; Newsum EC; Reijnierse M; Toes RE; Trouw LA; van der Helm-van Mil AH
    Arthritis Res Ther; 2016 Aug; 18():179. PubMed ID: 27485323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural changes and antibody enrichment in the lungs are early features of anti-citrullinated protein antibody-positive rheumatoid arthritis.
    Reynisdottir G; Karimi R; Joshua V; Olsen H; Hensvold AH; Harju A; Engström M; Grunewald J; Nyren S; Eklund A; Klareskog L; Sköld CM; Catrina AI
    Arthritis Rheumatol; 2014 Jan; 66(1):31-9. PubMed ID: 24449573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ACPA recognition profile and subgrouping of ACPA-positive RA patients.
    Willemze A; Böhringer S; Knevel R; Levarht EW; Stoeken-Rijsbergen G; Houwing-Duistermaat JJ; van der Helm-van Mil AH; Huizinga TW; Toes RE; Trouw LA
    Ann Rheum Dis; 2012 Feb; 71(2):268-74. PubMed ID: 21998120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
    van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
    Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCR6(+) Th cell populations distinguish ACPA positive from ACPA negative rheumatoid arthritis.
    Paulissen SM; van Hamburg JP; Davelaar N; Vroman H; Hazes JM; de Jong PH; Lubberts E
    Arthritis Res Ther; 2015 Nov; 17():344. PubMed ID: 26617177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
    Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
    Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage.
    Brink M; Verheul MK; Rönnelid J; Berglin E; Holmdahl R; Toes RE; Klareskog L; Trouw LA; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2015 Feb; 17(1):25. PubMed ID: 25889922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of high titers of anti-carbamylated protein antibodies with decreased bone mineral density in early arthritis patients.
    Regueiro C; Ortiz AM; Boveda MD; Castañeda S; Gonzalez-Alvaro I; Gonzalez A
    PLoS One; 2018; 13(8):e0202583. PubMed ID: 30118518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of hand and foot joints of patients with anticitrullinated peptide antibody positive arthralgia without clinical arthritis.
    Krabben A; Stomp W; van der Heijde DM; van Nies JA; Bloem JL; Huizinga TW; Reijnierse M; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 Sep; 72(9):1540-4. PubMed ID: 23334211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of anticitrullinated protein antibodies increases with age in healthy individuals at risk for rheumatoid arthritis.
    Alpizar-Rodriguez D; Brulhart L; Mueller RB; Möller B; Dudler J; Ciurea A; Walker UA; Von Mühlenen I; Kyburz D; Zufferey P; Mahler M; Bas S; Gascon D; Lamacchia C; Roux-Lombard P; Lauper K; Nissen MJ; Courvoisier DS; Gabay C; Finckh A
    Clin Rheumatol; 2017 Mar; 36(3):677-682. PubMed ID: 28110385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum cytokine profile of unaffected first-degree relatives of patients with rheumatoid arthritis.
    Barra L; Summers K; Bell D; Cairns E
    J Rheumatol; 2014 Feb; 41(2):280-5. PubMed ID: 24429173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.
    Sanmartí R; Cabrera-Villalba S; Gómez-Puerta JA; Ruiz-Esquide V; Hernández MV; Salvador G; Ramirez J; Viñas O; Cañete JD
    J Rheumatol; 2012 Oct; 39(10):1929-33. PubMed ID: 22859345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage System.
    Martin L; Steber WA; Lupton TL; Mahler M; Fitch CM; McMillan JD; Schmidt DR; Fritzler MJ
    J Rheumatol; 2015 May; 42(5):771-7. PubMed ID: 25641884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parity influences the severity of ACPA-negative early rheumatoid arthritis: a cohort study based on the Swedish EIRA material.
    Pikwer M; Orellana C; Källberg H; Pikwer A; Turesson C; Klareskog L; Alfredsson L; Saevarsdottir S; Bengtsson C
    Arthritis Res Ther; 2015 Dec; 17():358. PubMed ID: 26653988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.